Gynecology & Obstetrics Case report Open Access

  • ISSN: 2471-8165
  • Journal h-index: 7
  • Journal CiteScore: 0.44
  • Journal Impact Factor: 1.86
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days

Mini Review - (2023) Volume 9, Issue 1

Giant Ovarian Cyst Adenoma in Postmenopausal Women: A Mini Review
Elad Leron*
 
Department of Obstetrics and Gynecology, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer Sheva 8410101, Israel
 
*Correspondence: Elad Leron, Department of Obstetrics and Gynecology, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer Sheva 8410101, Israel, Email:

Received: 26-Dec-2022, Manuscript No. IPGOCR-23-15837; Editor assigned: 28-Dec-2022, Pre QC No. IPGOCR-23-15837 (PQ); Reviewed: 11-Jan-2023, QC No. IPGOCR-23-15837 (Q); Revised: 16-Jan-2023, Manuscript No. IPGOCR-23-15837 (R); Published: 23-Jan-2023, DOI: 10.36648/2471-8165.9.1.5

Abstract

An ovarian cyst is a sac filled with fluid or semisolid material that develops in the ovaries. Ovarian cysts can occur in women of any age, but they are more common in women who are still menstruating. Postmenopausal women have a lower risk of developing ovarian cysts. However, when they do occur, they are more likely to be cancerous. Giant ovarian cyst adenoma is a rare condition that affects postmenopausal women. This article will discuss giant ovarian cyst adenoma in a postmenopausal woman.

Keywords

Ovarian cyst; Women health; Mensuration

Introduction

Giant ovarian cyst adenoma is a type of ovarian cyst that is larger than 10 centimeters in diameter. Adenomas are benign tumors that develop in glandular tissue, such as the ovaries. Giant ovarian cyst adenomas are rare, but they can occur in postmenopausal women. They are usually unilateral, meaning they affect only one ovary. The cause of giant ovarian cyst adenoma is not known, but it is thought to be related to hormonal imbalances in the body.

Literature Review

Giant ovarian cyst adenoma may not cause any symptoms, especially in the early stages. However, as the cyst grows larger, it can cause a range of symptoms, including:

Abdominal swelling or distension

The cyst can grow to a large size, causing the abdomen to swell or become distended. As the cyst grows larger, it can cause pain in the pelvis or lower abdomen. This pain may be intermittent or constant. The cyst can put pressure on the bladder, causing a frequent need to urinate or difficulty in holding urine. In rare cases, the cyst can press against the intestines, causing a bowel obstruction. The cyst can affect the menstrual cycle, causing irregular periods or heavy bleeding. Giant ovarian cyst adenoma is usually diagnosed through imaging tests, such as an ultrasound or MRI. These tests can show the size and location of the cyst, as well as its structure and whether it is solid or filled with fluid. A blood test may also be done to check for tumor markers, such as CA-125. Elevated levels of this protein can be a sign of ovarian cancer. The treatment for giant ovarian cyst adenoma is usually surgery. The aim of surgery is to remove the cyst and preserve the ovary if possible. In some cases, a total hysterectomy may be necessary. The type of surgery depends on the size and location of the cyst, as well as the age and overall health of the patient. In some cases, laparoscopic surgery may be an option, which involves making small incisions in the abdomen and using a tiny camera and surgical instruments to remove the cyst.

Discussion

The prognosis for giant ovarian cyst adenoma is usually good, as it is a benign condition. However, there is a small risk that the cyst may be cancerous, especially in postmenopausal women. If cancer is detected, further treatment may be necessary, such as chemotherapy or radiation therapy. Regular follow-up appointments with a gynecologist are important to monitor for any recurrence or development of new cysts. Postmenopausal women are a group of women who have reached the stage of life where their menstrual periods have stopped. This occurs due to a natural decline in the production of hormones, specifically estrogen, by the ovaries. The age at which women reach menopause can vary but typically occurs between the ages of 45 and 55 years. Postmenopausal women are at risk for a variety of health issues due to hormonal changes and other factors. This article will discuss some of the common health issues and concerns that postmenopausal women face.

Osteoporosis is a common health issue for postmenopausal women. As estrogen levels decline, women lose bone density, which can lead to weakened bones and an increased risk of fractures. Regular exercise, a healthy diet rich in calcium and vitamin D, and medications can help prevent and treat osteoporosis.

Heart disease is the leading cause of death in women, including postmenopausal women. Estrogen helps protect against heart disease, and its decline after menopause puts women at increased risk. Lifestyle changes, such as quitting smoking, regular exercise, a healthy diet, and medication, can help reduce the risk of heart disease.

Breast cancer is a concern for postmenopausal women, as the risk of developing breast cancer increases with age. Regular mammograms and breast exams are important for early detection and treatment. Lifestyle changes, such as maintaining a healthy weight and reducing alcohol consumption, may help reduce the risk of breast cancer.

Urinary incontinence, or the involuntary leakage of urine, is more common in postmenopausal women due to changes in the bladder and urethra. Pelvic floor exercises and medications can help treat urinary incontinence. Vaginal atrophy, or the thinning and drying of the vaginal walls, can occur in postmenopausal women due to decreased estrogen levels. This can lead to vaginal itching, dryness, and pain during sexual intercourse. Vaginal moisturizers, lubricants, and estrogen therapy can help treat vaginal atrophy [1-6].

Depression is more common in postmenopausal women due to hormonal changes and other factors. Regular exercise, a healthy diet, and counseling can help treat depression. Postmenopausal women may experience sleep disturbances, such as difficulty falling asleep, staying asleep, or waking up too early. Lifestyle changes, such as avoiding caffeine and alcohol before bed and medications can help treat sleep disorders. Cognitive decline, including memory loss and difficulty with concentration, can occur in postmenopausal women due to hormonal changes and other factors. Regular exercise, a healthy diet, and cognitive stimulation can help prevent cognitive decline. Postmenopausal women may experience sexual dysfunction, such as decreased libido and difficulty achieving orgasm, due to hormonal changes and other factors. Counseling and medications can help treat sexual dysfunction.

Conclusion

Giant ovarian cyst adenoma is a rare condition that can affect postmenopausal women. While it is usually benign, there is a small risk of it being cancerous. Symptoms can include abdominal swelling or distension, pelvic pain, urinary urgency or frequency, bowel obstruction, and menstrual changes. Treatment usually involves surgery to remove the cyst, and the prognosis is usually good. Regular follow-up appointments with a gynecologist are important for monitoring. Postmenopausal women are at increased risk for a variety of health issues, including osteoporosis, heart disease, breast cancer, urinary incontinence, vaginal atrophy, depression; sleep disorders, cognitive decline, and sexual dysfunction. Regular exercise, a healthy diet, and medications can help prevent and treat these health issues. It is important for postmenopausal women to have regular check-ups with their healthcare providers to monitor for any health concerns and to discuss treatment options.

Acknowledgements

None.

Conflict of Interest

The author has no conflicts of interest to declare.

References

  1. Goto, Masaki, Shin-ichiro Miura, Tomohiko Yamamoto and Yusuke Fukuda, et al. "Anticoagulant therapy in a pregnant woman with May-Thurner syndrome." Intern Med 55 (2016): 59-62.
  2. [Google Scholar], [Crossref], [Indexed at]

  3. Mousa, Albeir Y. and Ali F. AbuRahma. "May–Thurner syndrome: update and review." Ann Vasc Surg 27(2013): 984-995.
  4. [Google Scholar], [Crossref], [Indexed at]

  5. American College of Obstetricians and Gynecologists. "ACOG practice bulletin no. 196: Thromboembolism in pregnancy." Obs Gynecol 132 (2018): e1-e17.
  6. [Google Scholar], [Crossref], [Indexed at]

  7. Labropoulos, Nicos and Luis R. Leon Jr. "Duplex evaluation of venous insufficiency." Semin Vasc Surg pp. 5-9. WB Saunders (2005).
  8. [Google Scholar], [Crossref], [Indexed at]

  9. Wethington SL, Wahner-Hendrickson AE, Swisher EM, Kaufmann SH, Karlan BY, et al. (2021) PARP inhibitor maintenance for primary ovarian cancer–A missed opportunity for precision medicine. Gynecol Oncol 163(1):11-13.
  10. [Google Scholar], [Crossref], [Indexed at]

  11. Chandra A, Pius C, Nabeel M, Nair M, Vishwanatha JK, et al. (2019) Ovarian cancer: Current status and strategies for improving therapeutic outcomes. Cancer Med 8(16):7018-7031.
  12. [Google Scholar], [Crossref], [Indexed at]

Citation: Leron E (2023) Giant Ovarian Cyst Adenoma in Postmenopausal Women: A Mini Review. Gynecol Obstet Case Rep. Vol.9 No.1:5.

Copyright: © Leron E. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.